Canada Veterinary Oxygen Therapy Market

Canada Veterinary Oxygen Therapy Market Insights Forecasts to 2035

• The Canada Veterinary Oxygen Therapy Market Size was estimated at USD 135.36 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.36% from 2025 to 2035
• The Canada Veterinary Oxygen Therapy Market Size is Expected to Reach USD 295.66 Million by 2035

According to a research report published by Decisions Advisors, The Canada Veterinary Oxygen Therapy Market is Anticipated to Reach USD 295.66 Million by 2035, Growing at a CAGR of 7.36% from 2025 to 2035. The increasing environment for pet ownership, an increase in the prevalence of respiratory illnesses in animals, and improvements in veterinary medications are the main drivers of the industry's growth. As a result of this trend, hospitals and veterinary clinics are expanding their services, like oxygen therapy, to treat more pets, which influences the market growth.

Market Overview

The market for veterinary oxygen therapy in Canada is a portion of the country's animal health sector dedicated to products, services, and equipment that provide oxygen therapy to pets for medical purposes such as critical care, wound healing, and respiratory support. The requirement is further increased by the requirements of elderly pets as well as issues with obesity, pollution, and other respiratory conditions. For the purpose of improving treatment outcomes for such diseases, medical facilities and veterinary clinics are utilising respiratory catheters, high-performance masks, and concentrators for oxygen. Further, growing ownership of pets and the growing prevalence of respiratory conditions in animals resulted in the development of therapeutic solutions in animal care, better health outcomes, and improved veterinary procedures.

Oxygen therapy is made more accessible through initiatives like Ontario's Assistive Devices Program, which subsidises up to 75% of the cost of home oxygen therapy equipment. Additionally, Veterans Affairs Canada offers authorised reimbursement for oxygen and respiratory equipment through its Program of Choice (POC 9). This program covers devices such as ventilators and oxygen concentrators that support veterans with respiratory conditions, including pets under specific care plans.

Report Coverage

This research report categorises the market for the Canada veterinary oxygen therapy market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada veterinary oxygen therapy market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada veterinary oxygen therapy market.

Driving Factors

Numerous important factors are driving the veterinary oxygen therapy market in Canada, one of them, the rising number of respiratory conditions in animals, including bronchitis, pneumonia, and chronic obstructive pulmonary disease (COPD). Moreover, the growing number of pet owners is being spent on cutting-edge veterinary care, which guarantees improved health outcomes through prompt and efficient oxygen therapy. Besides, the growing use of oxygen therapy equipment such as masks, high-flow delivery systems, and portable and stationary oxygen concentrators is supporting the growth of the veterinary industry's infrastructure, which includes speciality clinics and hospitals. Additionally, recent advances in technology have made oxygen therapy equipment more effective, portable, and user-friendly, making it possible to use.

RAPS Animal Hospital made significant strides in veterinary respiratory care by becoming the only facility in Canada to provide hyperbaric oxygen therapy (HBOT) for companion animals. This approach, which has been proven effective in human medicine, speeds up recovery and lowers inflammation, giving pets with serious illnesses new options for treatment.

Restraining Factors

Two major obstacles are preventing the Canadian companion animal cardiac drugs market from expanding further: significant financial limitations and operational difficulties with diagnosis and compliance. While heart disease is becoming more prevalent, these compliance issues limit the market's potential by triggering inconsistent drug purchases and worse results for patients.

Market Segmentation

The Canada veterinary oxygen therapy market share is classified into product and application.

• The veterinary oxygen concentrator segment dominated the market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The Canada veterinary oxygen therapy market is divided by product into veterinary oxygen concentrator, (stationary, portable) and accessories. Among these, the veterinary oxygen concentrator segment dominated the market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. Their efficacy, affordability, and ease of use are the reasons for the segment growth. Veterinary oxygen concentrators are more common than traditional oxygen cylinders because they provide a steady supply of oxygen from ambient air, removing the need for refills and saving veterinary clinics money on operating expenses. The portability and versatility of these veterinary oxygen concentrators make them appropriate for emergency care, mobile veterinary units, and small animal practices. Their growing popularity can be attributed to increased awareness of advanced critical care solutions and rising rates of respiratory diseases in companion animals.

• The intensive care segment held a substantial market share in 2024 and is projected to grow at a significant CAGR during the forecast period.

The Canada veterinary oxygen therapy market is segmented by application into intensive care, home care settings/postoperative care, and other applications. Among these, the intensive care segment held a substantial market share in 2024 and is projected to grow at a significant CAGR during the forecast period. The segmental growth is driven by the growing need for critical care facilities in speciality clinics and veterinary hospitals. Modern oxygen delivery systems are installed in intensive care units with 24-hour care, precise oxygenation, and ongoing monitoring are available to animals with severe respiratory conditions, trauma, or post-operative complications. The integration of temperature control, high-flow oxygen systems, and monitoring equipment all make them a recommended section that boosts the segment growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Canada veterinary oxygen therapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Vetoquinol SA
• Air Liquide Healthcare
• Zoetis Animal Healthcare
• IDEXX Laboratories
• Virbac Corporation
• Phibro Animal Health
• Others

Recent Developments:

• In January 2025, Infinium Medical partnered with Vapotherm to distribute the VET 2.0 high-flow oxygen therapy system in Canada. This system offers animal patients better mobility, ease of use, and medication delivery.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Canada, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Canada Veterinary Oxygen Therapy Market based on the below-mentioned segments:

Canada Veterinary Oxygen Therapy Market, By Product

• Veterinary oxygen concentrator (Stationary, Portable)
• Accessories

Canada Veterinary Oxygen Therapy Market, By Application 

• Intensive care
• Homecare setting/postoperative care
• Other applications